Covaxin 'data looks good', WHO approval likely by month end: Dr VK Paul | Editorji
editorji
/Assets/images/logo/Punchline_v2.png
download editorji appgoogle apple
  1. home
  2. > Covid-19
  3. > Covaxin 'data looks good', WHO approval likely by month end
prev icon/Assets/images/svg/play_white.svgnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Covaxin 'data looks good', WHO approval likely by month end

Sep 14, 2021 09:42 IST | By Editorji News Desk

The World Health Organization’s approval for India's Covid-19 vaccine Covaxin is likely to come by this month end.

Dr VK Paul, member of Niti Aayog and head of the Covid-19 task force, in an interview with India Today on Monday said that Covaxin's data looked promising and that it could soon get WHO approval.

Covaxin, developed by the Hyderabad-based Bharat Biotech, is one of the six vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

Sources within Bharat Biotech have also said that they expect the approval to come by "month-end" and that "all queries have been answered", India Today reported.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China's Sinopharm and Oxford-AstraZeneca for emergency use.

Covaxin 'data looks good', WHO approval likely by month end

1/3

Covaxin 'data looks good', WHO approval likely by month end

Covid-19: India to welcome foreign tourists for the first time in 19 months

2/3

Covid-19: India to welcome foreign tourists for the first time in 19 months

Govt allows airlines to operate 85% of pre-Covid-19 domestic flights

3/3

Govt allows airlines to operate 85% of pre-Covid-19 domestic flights

National